CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 32 enrolled
Drug / intervention
Peristeen cone catheterdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04586634
NCT04586634N/ACompleted

Randomized Clinical Trial Assessing the Effect of Transanal Irrigation With Cone Catheter Versus Conservative Bowel Management on Symptoms of Low Anterior Resection Syndrome After Rectal Resection

Coloplast A/S·interventional·Posted Oct 14, 2020·Updated Jul 22, 2024

In Brief

A clinical study evaluating Peristeen cone catheter for Low Anterior Resection Syndrome. Completed, enrolled 32 participants across 1 site.

Detailed Summary

Objective The primary objective is to demonstrate superiority of the Peristeen cone catheter compared to standard of care. The secondary objective is to investigate quality of life and different benefits and aspects of treatment and satisfaction with the Peristeen cone catheter. Design of the investigation This is a randomised, open-label, parallel investigation comparing the Peristeen cone catheter with standard of care in subjects with major LARS (LARS score ≥ 30). Each subject will be enrolled for a study duration of 12 weeks. Subjects will be randomized to the treatments stratified by neo-adjuvant radiotherapy. The comparator in this study will be current standard of care for patients with LARS which is conservative bowel management. This is defined as: Supportive therapy according to the individual treatment protocols available at each participating site. Primary endpoint and secondary endpoints Primary endpoint: • LARS score, obtained from the LARS score questionnaire\* Secondary endpoints: * Number of subjects with Major LARS\* * FIQL Score - scale 1, Modified American Society for Colorectal Surgeons Questionnaire\* * FIQL Score - scale 2, Modified American Society for Colorectal Surgeons Questionnaire\* * FIQL Score - scale 3, Modified American Society for Colorectal Surgeons Questionnaire\* * FIQL Score - scale 4, Modified American Society for Colorectal Surgeons Questionnaire\* * EQ-5D-5L - utility score\* * EQ-5D-5L - VAS score (scale 0-10 cm)\* * Satisfaction with treatment (scale 0-10 cm)\* * Number of adverse events\* \*All endpoints are measured per subject at study completion

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesDenmark

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedOct 14, 2020
Enrollment StartJan 21, 2020
Primary CompletionDec 10, 2021
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 5.7 years ago

Interventions

Peristeen cone catheterdevice

The active intervention is the Peristeen cone catheter device. The comparator in this investigation is current standard of care for patients with LARS which is conservative bowel management.